Dave Inc. enters July with a sharp tension at its core: short interest has nearly doubled over the past month, yet the stock just rallied 17% in a single week, leaving a crowded bear trade nursing fresh losses.
The positioning picture is genuinely uncomfortable for shorts. Short interest climbed to 21% of the free float — up roughly 82% over the past 30 days, with the majority of that buildup occurring in the second half of June. Yet borrow conditions offer little sign of distress for those already short: cost to borrow remains low at 0.45%, down 71 basis points on the week, and availability has tightened from above 400% in late May to around 146% today, a meaningful move but still within the normal range. The borrow market is not squeezing — it is simply absorbing a larger short book at cheap rates. Options traders are leaning in the same direction as the stock: the put/call ratio has drifted below its 20-day average to 0.46, roughly a standard deviation below the mean, suggesting call-side demand has picked up alongside the price move.
The Street is broadly constructive, though targets are now playing catch-up with the share price. Benchmark's Mark Palmer raised his target to $475 from $345 on July 1 — the most aggressive recent move — while the consensus mean sits around $347, already below the current $372.59 close. That inversion, where the stock has run through the average target, reflects a theme playing out across several recent analyst actions: UBS and Evercore ISI both initiated coverage in late May with targets of $300 and $260 respectively, levels the stock has already surpassed. The bull case centres on DaveFlex, a new pay-in-4 product, and continued momentum in the ExtraCash franchise; bears point to the removal of the $15 fee cap for new members and uncertain unit economics in that transition. Valuation multiples have moved firmly higher — the price-to-book ratio has expanded by 2.5 turns in 30 days to nearly 8x, and the trailing P/E has re-rated from around 12.8x to 17.4x over the same period. The ORTEX analyst recommendation divergence score ranks in the 93rd percentile, meaning the spread between bull and bear analyst positioning is unusually wide relative to the broader universe.
Insider activity adds a cautionary note to the otherwise bullish narrative. CEO Jason Wilk sold approximately $2.3 million worth of shares on June 2, at prices around $275, while CFO Kyle Beilman sold over $1.1 million on the same day. Those sales came as the stock was trading nearly 25% below where it closed the week. Director Dan Preston followed with smaller sales on June 4 and June 5. The 90-day net insider figure is a positive 16,407 shares, but that reflects accumulated equity compensation rather than open-market buying — every discrete recent transaction in the data is a sale. That pattern is consistent with routine plan-based selling, but the concentration on a single day at the C-suite level is worth noting.
The earnings history adds another layer of context. DAVE's two most recent quarterly prints each produced an immediate one-day loss of close to 12%, with the May 5 result extending to a five-day loss of over 13%. The next earnings event is scheduled for August 4. The question heading into that date is whether the stock's rally — now up 32% over the past month — has priced in an outcome that the company's own recent track record suggests is far from guaranteed.
See the live data behind this article on ORTEX.
Open DAVE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
